HCV

Free 2013 Report: New HIV, HCV and TB Drugs, Diagnostics, and Vaccines in the Research Pipeline

HIV i-Base/Treatment Action Group 2013 Pipeline Reportcalls on leaders to get the best HIV, hepatitis C virus (HCV), and tuberculosis drugs, diagnostics, and vaccines to the most people as quickly as possible– Survey shows HIV pipeline healthy, HCV drug development surging,while TB research moves forward much too slowly – – Faster research, approval, and access demanded …

Free 2013 Report: New HIV, HCV and TB Drugs, Diagnostics, and Vaccines in the Research Pipeline Read More »

HIV, Active HCV, Low Income Tied to Shorter Telomeres, a Cellular Aging Marker

From Natap.org HIV, Active HCV, Low Income Tied to Shorter Telomeres, a Cellular Aging Marker3rd International Workshop on HIV and Aging, November 5-6, 2012, Baltimore Mark Mascolini HIV infection, active HCV infection, and income below $15,000 a year independently predicted shorter telomere length in a study of 229 HIV-positive people and 166 HIV-negative people in …

HIV, Active HCV, Low Income Tied to Shorter Telomeres, a Cellular Aging Marker Read More »